The potential savings a strong integrated product development (IPD) strategy can provide biopharma companies cannot be underestimated, but the most significant challenge to its success requires a dramatic shift in culture.
One industry analysis found that IPD, when coupled with innovative research and development, had the ability to cut 500 days from a drug development cycle and 25% off the bottom line.
It’s a message being heard by a growing nu…